Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice.

After intravenous (iv) injection of 125I-labeled poly(ethylene glycol) (PEG) with different molecular weights to mice, the radioactivity of the organs was measured to pharmacokinetically analyze the body distribution of PEG according to a two-compartment model. High molecular weight PEGs were retained in the blood circulation for a longer period than low molecular weight PEGs. The terminal half-life of PEG in the circulation extended from 18 min to 1 day as the PEG molecular weight increased from 6000 to 190,000. PEG tended to accumulate in the tissues/organs such as muscle, skin, bone, and the liver to a higher extent than the other organs, irrespective of the molecular weight. The time dependence of tissue accumulation was based on the vascular permeability. The results of pharmacokinetic analysis suggested that small PEG tended to freely translocate from the circulation to extravascular tissues and to return to the blood circulation again by diffusion, whereas large PEG translocated more slowly to extravascular tissues. Urinary clearance decreased with increasing PEG molecular weight, similar to the tissue clearance, whereas liver clearance increased with the increasing PEG molecular weight, after passing a minimum around the molecular weight of 50,000. PEG uptake by Kupffer cells was enhanced as the molecular weight became > 50,000.

[1]  P. Caliceti,et al.  PREPARATION, PHYSICO-CHEMICAL AND PHARMACOKINETIC CHARACTERIZATION OF MONOMETHOXYPOLY(ETHYLENE GLYCOL)- DERIVATIZED SUPEROXIDE DISMUTASE , 1989 .

[2]  M. Jozefowicz,et al.  Contributions of negatively charged chemical groups to the surface-dependent activation of human plasma by soluble dextran derivatives. , 1989, Biomaterials.

[3]  C. White,et al.  Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. , 1988, The Journal of biological chemistry.

[4]  K E Magnusson,et al.  Characterization of size-dependent exchange of PEG molecules between the blood and extravascular space in the pig. , 1988, Computers and biomedical research, an international journal.

[5]  M. Hashida,et al.  The Accumulation Mechanism of Cationic Mitomycin C‐dextran Conjugates in the Liver: In‐vivo Cellular Localization and In‐vitro Interaction with Hepatocytes , 1988, The Journal of pharmacy and pharmacology.

[6]  W. Laird,et al.  Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Wada,et al.  Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. , 1986, Japanese journal of cancer research : Gann.

[8]  Y. Ikada,et al.  Phagocytosis of Bioactive Microspheres , 1986 .

[9]  F. Veronese,et al.  Anti‐inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters , 1983, The Journal of pharmacy and pharmacology.

[10]  S. Pizzo,et al.  A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin. , 1983, Analytical biochemistry.

[11]  D. Knook,et al.  Quantitative determination of in Vivo endocytosis by rat liver kupffer and endothelial cells facilitated by an improved cell isolation method , 1982 .

[12]  F. Davis,et al.  Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice. , 1982, Clinical and experimental immunology.

[13]  K. Ajisaka,et al.  Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute. , 1980, Biochemical and biophysical research communications.

[14]  B. Chu,et al.  The interaction of carrier-bound methotrexate with L1210 cells. , 1980, Molecular pharmacology.

[15]  Y. Ashihara,et al.  Modification of E. coli L-asparaginase with polyethylene glycol: disappearance of binding ability to anti-asparaginase serum. , 1978, Biochemical and biophysical research communications.

[16]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[17]  D. Knook,et al.  Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. , 1976, Experimental cell research.

[18]  P. Seglen,et al.  Mass isolation and culture of rat kupffer cells , 1975, The Journal of experimental medicine.

[19]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[20]  R. Cowgill.  Colorimetric Method for Analysis of Histidine and Certain Related Imidazole Compounds , 1955 .

[21]  H. F. Deutsch,et al.  Clearances of some proteins by the dog kidney. , 1950, The American journal of physiology.

[22]  J. Jones,et al.  Clearance of charged and uncharged dextrans from normal and injured lungs. , 1990, Journal of applied physiology.

[23]  J. Svanvik,et al.  Hepatic clearance of polyethylene glycol 900 and mannitol in the pig. , 1988, Digestion.

[24]  H. F. Woods,et al.  Phagocytic function in the isolated perfused rat liver. An experimental model. , 1985, Journal of hepatology.

[25]  Y. Inada,et al.  Suppression of IgE antibody response against ovalbumin by the chemical conjugate of ovalbumin with a polyaspartic acid derivative. , 1985, International archives of allergy and applied immunology.

[26]  E. Åkerblom,et al.  Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors. , 1984, International archives of allergy and applied immunology.

[27]  A. Sehon,et al.  Suppression of Reaginic Antibodies with Modified Allergens , 1978 .